Medpage Today on MSN
Semaglutide's MASH Benefits Extend Beyond Weight Loss
WASHINGTON -- Semaglutide (Wegovy) improved liver inflammation and fibrosis in patients with metabolic dysfunction-associated ...
Danish drugmaker Novo Nordisk has teamed up with Emcure Pharmaceuticals to increase access to its weight-loss drug ...
Weight loss refers to a reduction in overall body weight, while fat loss specifically targets excess body fat, improving body ...
Clinicians prescribing GLP-1 agents should ask about sexual function and consider medication review if new anorgasmia appears.
Novo Nordisk India has joined forces with Emcure Pharmaceuticals to commercialize Poviztra, a weight-loss drug, in an effort ...
Danish drugmaker Novo Nordisk has partnered Emcure Pharmaceuticals to commercialise Poviztra, a 2.4 milligram (mg) ...
Below, doctors explain everything you need to know about the phenomenon. It’s important to be clear upfront that “Ozempic ...
Novo Nordisk is under pressure from cheap copycats, a Trump pricing deal, and Lilly's fast-growing Zepbound juggernaut.
rocketcitynow.com on MSN
Alabama AG orders temporary shutdown of Cullman IV clinic due to unsafe weight loss drugs
Alabama Attorney General Steve Marshall has shut down a Cullman IV clinic after allegations it gave patients unsafe, research ...
Alabama Attorney General Steve Marshall says that a Cullman County Circuit Court approved his request for a temporary ...
The Combating Counterfeit Pharmaceuticals Act, which would amend the Fentanyl Sanctions Act, is authored by Sens. Tom Cotton ...
News-Medical.Net on MSN
GLP-1 drugs beat metformin for weight control in teens with type 2 diabetes
In youth newly diagnosed with type 2 diabetes, GLP-1–based therapies, including semaglutide and tirzepatide, achieved similar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results